Suppr超能文献

A亚基C末端抑制促甲状腺素受体组成性活性的证据。

Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity.

作者信息

Chen Chun-Rong, Chazenbalk Gregorio D, McLachlan Sandra M, Rapoport Basil

机构信息

Autoimmune Disease Unit, Cedars-Sinai Research Institute and School of Medicine, University of California, Los Angeles, California 90048, USA.

出版信息

Endocrinology. 2003 Sep;144(9):3821-7. doi: 10.1210/en.2003-0430.

Abstract

The TSH receptor (TSHR), unlike the LH receptor (LHR), has considerable ligand-independent adenylyl cyclase activity, a feature of pathophysiological importance. The TSHR ectodomain partially suppresses constitutive activity, an effect reversed by trypsin treatment of intact cells. Localizing the functional site of trypsin action would provide insight into how the TSHR ectodomain exerts its constraint. For this purpose, we examined the effect of trypsin on intact cells expressing a series of modified TSHR. Trypsin did not increase cAMP production by a chimeric TSH-LH receptor involving substitution of TSHR residues 261-418 (the ectodomain C terminus). In contrast, with the wild-type TSHR, trypsin enhanced constitutive activity despite mutation of the following potential tryptic cleavage sites [arginine (R) and lysine (K) residues]: 1) K565, K651, K660 in the extracellular loops of the serpentine region; 2) B subunit juxtamembrane residues K371, K401, K415; 3) A subunit residues R310, R312, K313. We previously excluded K337 and K339 from being implicated in TSHR tryptic activation. By exclusion, only one R/K cluster remains as a possible target for the functional effect of trypsin, namely K287, K290, K291, and R293. Mutation of this cluster is incompatible with TSHR cell surface expression. However, tryptic clipping at this locus would reproduce a previously demonstrated structural effect of trypsin on the TSHR, removal of about a 2-kDa polypeptide fragment extending downstream from the locus to the C terminus of the A subunit. Taken together, these data suggest that the C terminus of the A subunit functions as a suppressor of TSHR constitutive activity.

摘要

促甲状腺激素受体(TSHR)与促黄体生成素受体(LHR)不同,具有相当可观的非配体依赖性腺苷酸环化酶活性,这一特性具有病理生理学重要意义。TSHR胞外域部分抑制组成性活性,完整细胞经胰蛋白酶处理后这种效应会逆转。确定胰蛋白酶作用的功能位点将有助于深入了解TSHR胞外域如何发挥其抑制作用。为此,我们研究了胰蛋白酶对表达一系列修饰TSHR的完整细胞的影响。胰蛋白酶不会通过涉及TSHR残基261 - 418(胞外域C末端)替换的嵌合TSH - LH受体增加环磷酸腺苷(cAMP)的产生。相比之下,对于野生型TSHR,尽管以下潜在的胰蛋白酶切割位点[精氨酸(R)和赖氨酸(K)残基]发生了突变,但胰蛋白酶仍增强了组成性活性:1)蛇形区域细胞外环中的K565、K651、K660;2)B亚基近膜残基K371、K401、K415;3)A亚基残基R310、R312、K313。我们之前已排除K337和K339与TSHR胰蛋白酶激活有关。通过排除法,只有一个R/K簇作为胰蛋白酶功能效应的可能靶点保留下来,即K287、K290、K291和R293。该簇的突变与TSHR细胞表面表达不兼容。然而,在此位点的胰蛋白酶切割将重现先前证明的胰蛋白酶对TSHR的结构效应,即去除从该位点向下游延伸至A亚基C末端的约2 kDa多肽片段。综上所述,这些数据表明A亚基的C末端作为TSHR组成性活性的抑制剂发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验